The objective of this study was to improve the prediction of the impact of HIV-1 protease mutations in different viral subtypes on virological response to darunavir.
De Luca, A., Flandre, P., Dunn, D., Zazzi, M., Wensing, A., Santoro, M., et al. (2016). Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71(5), 1352-1360 [10.1093/jac/dkv465].
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen
Santoro, Mm;PERNO, CARLO FEDERICO;
2016-05-01
Abstract
The objective of this study was to improve the prediction of the impact of HIV-1 protease mutations in different viral subtypes on virological response to darunavir.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
2016_Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B_J Antimicrob Chemother.pdf
solo utenti autorizzati
Descrizione: principal article
Licenza:
Copyright dell'editore
Dimensione
312.43 kB
Formato
Adobe PDF
|
312.43 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.